Sort
40,608 grants matching “prostate cancer”
Mutagenesis Screen for Prostate Cancer
$417,818Grant D Trobridge · Washington State University · R15 · FY2013 · CA
Designing Magnetic Resonance Protein-based Contrast Agents with High Relaxivity
$417,812Jenny J Yang · Georgia State University · R01 · FY2014 · EB
Validation of pancreatic cancer biomarkers in large prospective cohorts
$417,779Anna E Lokshin · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · CA
A pooling project on alcohol use and risk of cancers with inconsistent prior evidence, with an emphasis in non-smokers.
$417,778Pietro Ferrari · International Agency For Res On Cancer · R01 · FY2018 · AA
Evaluation of Immune-based Combinations in Prostate Cancer
$417,740Ravi Madan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Defining Roles for PSMA PET Imaging in Prostate Cancer
$417,740Ravi Madan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Decision Aids to Address Prostate Cancer Disparities in Minority Men
$417,707Jon C Tilburt · Mayo Clinic Rochester · R01 · FY2014 · MD
COMPUTATIONAL TOOLS FOR CANCER PROTEOMICS
$417,645Katheryn A Resing · University Of Colorado · R01 · FY2007 · CA
UNDERSTANDING THE ROLE OF TUMOR DORMANCY IN TREATMENT PROSTATE CANCER
$417,565University Of Nottingham (The) · · FY2017 · Department of the Army
CONTROL OF METASTATIC COLONIZATION IN PROSTATE CANCER: THE FUNCTIONAL MECHANISM OF METASTASIS SUPPRESSION BY JNNKK1/MKK4
$417,485University Of Chicago · · FY2009 · Department of the Army
Modulators of Prostate Cancer Metastasis
$417,428Bruce R Zetter · Boston Children'S Hospital · R37 · FY2007 · CA
Nucleic Acid Nanoparticle-based Monoclonal Antibody Mimics
$417,416Emil Khisamutdinov · Ball State University · R15 · FY2021 · EB
Epigenetic mechanisms of drug resistance in renal cell carcinoma
$417,407Roberto Pili · Indiana University Indianapolis · R01 · FY2019 · CA
Chromosome 19 q-arm Polymorphism and Glioma Development
$417,401Ping Yang · Mayo Clinic Rochester · P50 · FY2007 · CA
Regulation of tyrosine kinase signaling through interaction with membrane lipids
$417,399Angela L Tyner · University Of Illinois At Chicago · R01 · FY2019 · CA
Project 1 High-order assembly of MegaTrans complexes for hormone-independent enhancer activation
$417,396Zhijie "jason" Liu · University Of Texas Hlth Science Center · U54 · FY2018 · CA
Modulators of Prostate Cancer Metastasis
$417,373Bruce R Zetter · Boston Children'S Hospital · R37 · FY2006 · CA
TARGETING FYN IN PROSTATE CANCER: A KEY REGULATOR OF GROWTH AND MOTILITY.
$417,371University Of Chicago · · FY2008 · Department of Defense
Microwave Treatment of Localized Prostate Cancer
$417,367Mmtc, Inc. · R44 · FY2001 · CA
MECHANISM OF ACTIVATION BY NUCLEAR RECEPTOR COACTIVATORS
$417,360University Of Southern California · R01 · FY2002 · DK
Regulation and Role of Ornithine Decarboxylase in Cell Proliferation and Cancer
$417,344John L. Cleveland · Scripps Research Institute, The · R01 · FY2012 · CA
Regulation and Role of Ornithine Decarboxylase in Cell Proliferation and Cancer
$417,344John L. Cleveland · Scripps Research Institute, The · R01 · FY2011 · CA
Project 3: Analysis of intrinsic and extrinsic factors that promote prostate neuroendocrine differentiation
$417,229Michael M. Shen · Columbia University Health Sciences · P01 · FY2024 · CA
Developmental Funds
$417,200Caryn Lerman · University Of Southern California · P30 · FY2025 · CA
Elucidating the somatic genetics of prostate cancer
$417,172Dana-Farber Cancer Institute · R01 · FY2005 · CA